WYETH
Patent Owner
Stats
- 648 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Aug 17, 2017 most recent publication
Details
- 648 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 53,593 Total Citation Count
- Mar 10, 1980 Earliest Filing
- 2,261 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9592284 Immunization regimen with E4-deleted adenovirus prime and E1-deleted adenovirus boostApr 27, 05Mar 14, 17[A61K, C12N, C07K]
9296795 Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infectionsMar 04, 04Mar 29, 16[A61K, C07K]
8828416 Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injuryMar 09, 04Sep 09, 14[A61F, A61L]
8802018 Apparatus and method for radiation processing of fluent food productsFeb 08, 06Aug 12, 14[B01J]
8795675 Allergy inhibitor compositions and kits and methods of using the sameDec 20, 12Aug 05, 14[A61K, C07H, C12P, C12N]
8784860 Local administration of a combination of rapamycin and cilostazol for the treatment of vascular diseaseOct 27, 05Jul 22, 14[A61F]
8747881 Intraluminal medical devices in combination with therapeutic agentsMay 18, 05Jun 10, 14[A61F]
8652502 Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injuryDec 19, 03Feb 18, 14[A61F]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8367688 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4ExpiredApr 13, 10Feb 05, 13[A61K, C07D]
2012/0134,958 HYDROXYETHYL STARCH-CONTAINING POLYPEPTIDE COMPOSITIONSAbandonedFeb 02, 12May 31, 12[A61K, A61P]
8163729 Modulators of α7 nicotinic acetylcholine receptors and therapeutic uses thereofExpiredJan 16, 08Apr 24, 12[A61K, C07D, A61P]
8158642 Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4ExpiredOct 15, 09Apr 17, 12[A61K, A01N, C07D]
2012/0059,025 DRY POWDER COMPOUND FORMULATIONS AND USES THEREOFAbandonedSep 12, 11Mar 08, 12[A61K, A61P]
2011/0177,960 Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniaeAbandonedMar 09, 07Jul 21, 11[C40B]
7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ExpiredDec 22, 09Jul 05, 11[A01N, C07D]
7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ExpiredDec 14, 09Jun 28, 11[A61K, C07D]
2011/0105,573 BENZIMIDAZOLE ACETIC ACIDS EXHIBITING CRTH2 RECEPTOR ANTAGONISM AND USES THEREOFAbandonedJun 08, 10May 05, 11[A61K, C12N, C07D, A61P]
2011/0091,415 Hydroxyethyl Starch-Containing Polypeptide CompositionsAbandonedNov 08, 10Apr 21, 11[A61K, A61P]
7897174 Formulation comprising bioactive agents and method of using sameExpiredFeb 10, 03Mar 01, 11[A61K]
2011/0027,324 O-DESMETHYL-VENLAFAXINE FOR TREATING MAJOR DEPRESSIVE DISORDERAbandonedDec 10, 07Feb 03, 11[A61K, A61P]
7875590 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteinsExpiredMar 31, 09Jan 25, 11[A61K, A61F]
7875618 Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disordersExpiredNov 25, 08Jan 25, 11[A61K]
7867699 Method of synthesizing and purifying Dkk proteins and Dkk proteins obtained therebyExpiredMar 23, 05Jan 11, 11[A01N, C07K]
2010/0297,147 COMPOSITIONS AND METHODS FOR MODULATING TLR14 ACTIVITYAbandonedOct 18, 07Nov 25, 10[A61K, C12Q, C12N, G01N, A61P, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
